Prokarin™ (formerly known as Prokarin) is a drug that has been successfully used to improve patients with multiple sclerosis. It combines a histamine with caffeine. It is an alternative medicine compounded specifically for the patient.
The original Prokarin™ formula was a compounded transdermal gel. The gel was measured out of topical syringes and applied to a plastic patch & applied to the skin twice a day. With the use of a patch, the active ingredients in Prokarin™ are applied to the patient’s skin and then absorbed into the bloodstream. Prokarin™ incorporates two key natural chemical derivatives, both of which have been FDA approved for many years. The Prokarin™ therapy, discovered and presented to the MS (Multiple Sclerosis) community by Elaine DeLack RN, is based on a study of scientific literature spanning nearly a decade. It was when she applied for a ‘use patent’ on Prokarin™ that she discovered the older related work of Dr. Jonez. Dr. Jonez based his work on Dr. Horton’s at the world famous Mayo Clinic in the 1930s and 1940s. Prokarin™ must be compounded by an EDMS licensed pharmacy, trained in its proper formulation.
Elaine DeLack, a nurse, was diagnosed with multiple sclerosis in 1988. She began researching multiple sclerosis in 1993 and experimented with a trans-dermal histamine-caffeine compound. She claims to have experienced instant relief and withdrawal of symptoms. However, Prokarin™ has never been clinically tested on a wide scale. DeLack originally named the compound "Prokarin." Pfizer, Inc. challenged the trademark stating that "Prokarin" could be confused with their medication, Procardia. So the spelling was changed to "Prokarin™." In 2005, DeLack wrote and self-published the book, They Said It Didn't Make "Cents"-MS-The Prokarin Story, describing her struggle of trying to bring Prokarin™ into mainstream medicine.
How Prokarin™ may help to alleviate MS symptoms...
Our nerve cells communicate with the transmission of certain chemicals, and our bodies also use these chemicals in times of stress. Inadequate production of one of these neurotransmitters results in difficulty sending messages between the nerves, heat intolerance, myelin self-degeneration, fatigue, depression, a poor sense of well-being, digestive problems, immune suppression, and the inability to tolerate stress. MS sufferers commonly experience symptoms involving all of these functions of the body, which are dependent on the availability of this chemical neurotransmitter.
It is theorized that by replenishing this chemical neurotransmitter, the symptoms that many MS sufferers experience will be reduced or alleviated. In a published double-blind study as well as two published clinical studies, MS patients receiving Prokarin™ demonstrated improvement in fatigue, hand dexterity, walking, balance, bladder function, cognition, and heat sensitivity.